Permanently classifies fentanyl-related drugs as schedule I

Congress approved bill s331-119 ("Permanently classifies fentanyl-related drugs as schedule I"), by a recorded vote of 401 to 120. Last action: July 16, 2025.

Congress file s331-119, before Congress. Passed as of 2025-07-16.

What it does

Offenses with fentanyl analogs trigger same mandatory minimums Possession or distribution of 100+ grams of fentanyl-related substances now automatically triggers a 10-year mandatory minimum prison sentence, matching penalties for fentanyl itself, effective immediately.

The bigger picture

Research access to fentanyl analogs streamlined for scientists New registration pathways and reduced inspection requirements for schedule I research sites allow legitimate pharmaceutical and academic researchers to study fentanyl-related compounds more efficiently, potentially accelerating pain medication development.

What to watch

Permanent scheduling limits future flexibility on new compounds The blanket schedule I classification covers all future structural variants of fentanyl, which may inadvertently capture legitimate pharmaceutical compounds and removes Congress's ability to respond if medical benefits of certain analogs are later discovered.

Official summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the act establishes a new, alternative registration process for certain schedule I research.The act also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities

How they voted

Yes (401)

No (120)

Did not vote / other (7)

Read the official record for s331-119

See everything up for a vote · This week in Congress · See what we have filed with the clerk